CoChat

Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)

Open access
Zampetti, S., Spoletini, M., Petrone, A., Capizzi, M., Arpi, M. L., Tiberti, C., Di Pietro, S., Bosi, E., Pozzilli, P., Giorgino, F., Buzzetti for the NIRAD Study Group, R. · 2010 · Diabetic Medicine
Cited by 54

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 27, 701–704 (2010) Aims We previously demonstrated the presence of two different populations among adult‐onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA). The transcription factor 7‐like 2 (TCF7L2) gene has been recognized as the major gene associated with Type 2 diabetes. The aim of the present study was to evaluate whether the phenotypic heterogeneity of LADA based on GADA titre is associated with TCF7L2 polymorphisms. Methods Two hundred and fifty patients identified as LADA, divided into two subgroups with low (≤ 32 arbitrary units) or high (> 32 units) GADA titre, 620 subjects with Type 2 diabetes [from the Non‐Insulin Requiring Autoimmune Diabetes (NIRAD) study cohort of 5330 subjects] in addition to 551 consecutive cases of Type 1 diabetes and 545 normoglycaemic subjects were analysed for the rs12255372 and rs7903146 polymorphisms of the TCF7L2 gene using Taqman. Results The genotype and allele distributions of the two polymorphisms revealed similar frequencies in subjects with low GADA titre and Type 2 diabetes. High GADA titre, Type 1 diabetes and controls also showed comparable frequencies. A significant increase of GT/TT genotypes of the rs12255372 single‐nucleotide polymorphism (SNP) and CT/TT genotypes of the rs7903146 SNP was observed in low GADA titre and Type 2 diabetes compared with high GADA titre, Type 1 diabetes and controls (P ≤ 0.04 for both comparisons). The risk alleles of both variants were increased in low GADA titre and Type 2 diabetes compared with high GADA titre, Type 1 diabetes and control subjects (P < 0.02 for all comparisons). Conclusions TCF7L2 common genetic variants of susceptibility are associated only with low GADA antibody titre in LADA patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.02997.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 54

Metadata

Authors
Zampetti, S., Spoletini, M., Petrone, A., Capizzi, M., Arpi, M. L., Tiberti, C., Di Pietro, S., Bosi, E., Pozzilli, P., Giorgino, F., & Buzzetti for the NIRAD Study Group, R.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-05-20
Volume
27
Issue
6
Pages
701-704
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1531029954
Cited by
54
References
3
FWCI
2.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.02997.x
The paper
Zampetti, S., Spoletini, M., Petrone, A., Capizzi, M., Arpi, M. L., Tiberti, C., Di Pietro, S., Bosi, E., Pozzilli, P., Giorgino, F., & Buzzetti for the NIRAD Study Group, R. (2010). Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.02997.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.